Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+34.28%
+6.50%
-6.76%
+1.93%
+1.43%
CLDX
Celldex Therapeutics
$26.41
Login to see Celldex Therapeutics (CLDX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid Strengths
Earnings are forecast to grow
Chart
$24.3 (+8.68%)
$23.31 (+13.30%)
$18.81 (+40.40%)
$28.25 (-6.51%)
CLDX has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
CLDX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
CLDX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
CLDX Street view is unimpressive and have negative views on the near-term outlook
Average key support and resistance price levels.
Login to displayCLDX Earnings
The TTM reflects 12-month period, providing review of CLDX financial performance.
The company financial health has deteriorated over the past year
Financial Score
What is CLDX current stock price?
What are CLDX stock strengths?
What risks are associated with CLDX stock?
When is CLDX next earnings report?
What is CLDX market cap and volume?
What is CLDX's current Stock IQ?
Should I buy CLDX stock right now?
Is CLDX a Strong Buy right now?
What does a 'Strong Buy' rating mean for CLDX?
What does a 'Strong Sell' rating mean for CLDX?
What factors influence CLDX's Stock IQ?
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+34.28%
+6.50%
-6.76%
+1.93%
+1.43%
CLDX
Celldex Therapeutics
Current Price
$26.41
Stock Insights
Strengths
Earnings are forecast to grow
Login to unlock Celldex Therapeutics (CLDX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
Chart
$24.3 (+8.68%)
$23.31 (+13.30%)
$18.81 (+40.40%)
$28.25 (-6.51%)
CLDX Analysts Opinion
CLDX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
CLDX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
CLDX Street view is unimpressive and have negative views on the near-term outlook
CLDX has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
Average key support and resistance price levels.
Login to displayCLDX Earnings
The TTM data reflects the most recent 12-month period, providing overview of CLDX financial performance.
CLDX Financial Health
The company financial health has deteriorated over the past year
Financial Score
CLDX Latest Analysis
5 Analysts Assess Celldex Therapeutics: What You Need To Know. Celldex Therapeutics (NASDAQ:) has been analyzed by 5 analysts in the last three months revealing a diverse range of perspectives from ish to bearish.The following table summarizes their recent ratings shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.4100010000310000000000000Providing deeper insights analysts have established 12-month price targets indicating an average targ
Wed Sep 17, 2025
Celldex Presents Data Demonstrating Barzolvolimab Improves Chronic Spontaneous Urticaria Independent of Baseline Immunoglobulin E levels in Phase 2 Study at EADV Congress 2025. Rapid and sustained efficacy regardless of baseline IgE levels in patients with CSU
Wed Sep 17, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
CLDX Stock trends
CLDX Stock performance
CLDX Stock analysis
CLDX investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings